Jane Street’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Jane Street’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-33,981	Closed	-$536K	–	10393
2023 Q4	$536K	Buy	+33,981	New	+$327K	﹤0.01%	6642
2023 Q2	–	Sell	-29,866	Closed	-$173K	–	9831
2023 Q1	$173K	Buy	29,866 +16,253	+119%	+$140K	﹤0.01%	7932
2022 Q4	$108K	Sell	13,613 -12,315	-47%	-$52.9K	﹤0.01%	8048
2022 Q3	$82K	Buy	+25,928	New	+$162K	﹤0.01%	8744
2022 Q2	–	Sell	-42,765	Closed	-$301K	–	11248
2022 Q1	$301K	Buy	+42,765	New	+$673K	﹤0.01%	8403

Jane Street's ICVX Position: Q1 2024 in Review

Jane Street sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 33,981 shares — an estimated $536K sold.

Jane Street first reported a position in ICVX in Q1 2022 and held it in 5 quarters. The position peaked at $536K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Jane Street reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jane Street sold 33,981 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $536K.
Jane Street first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Jane Street's Icosavax, Inc. Common Stock position peaked at $536K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.